INIS
tumors
100%
antigens
18%
immunosuppression
18%
therapy
18%
tumor cells
18%
vaccines
18%
cancer
9%
gain
9%
reduction
9%
mice
9%
clinical trials
9%
cell membranes
9%
nmr imaging
9%
permeability
9%
immunotherapy
9%
fibrosis
9%
pancreas
9%
lymph nodes
9%
cadmium sulfides
9%
barriers
9%
metastases
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
72%
Tumor Microenvironment
27%
Vaccine
18%
Clinical Trial
18%
Mouse
9%
Malignant Neoplasm
9%
Metastasis
9%
Antigen
9%
Fibrosis
9%
Tumor Antigen
9%
Immunotherapy
9%
Systemic Treatment
9%
Primary Tumor
9%
Immunology and Microbiology
Cytotoxic T Cell
36%
Vaccine Efficacy
18%
Electric Potential
18%
Immunosuppression
18%
Lymph Node
9%
Tumor Cell
9%
Immunotherapy
9%
Cell Membrane
9%
Permeability
9%
Tumor Antigen
9%
Electroporation
9%
Reduction (Chemistry)
9%
Mouse
9%